Cristae: bridging bioenergetic hubs and compartmental barriers in mitochondrial homeostasis

However, identifying these evolutionary roots is only the beginning. To fully harness this knowledge for biomedical advancement, future research must transition from static structural descriptions to dynamic functional mechanistic studies. We propose four key frontiers for the next decade of cristae research:

(1) From static structure to 4D dynamics: emerging advances in imaging are revolutionizing our view of cristae. While electron microscopy provided static snapshots, the future lies in live-cell super-resolution nanoscopy (e.g., STED, SIM) and in situ Cryo-electron tomography. These technologies will allow researchers to visualize how this bacterial-like remodeling traits operate in real-time within eukaryotic cells—specifically, how cristae open and close within milliseconds to act as metabolic switches during rapid physiological changes.

(2) Deciphering tissue-specific heterogeneity: cristae regulation is not uniform; it is highly context-dependent. Understanding why cristae architecture differs between energy-storage tissues (adipose) and energy-demanding tissues (heart/brain) will be crucial for developing organ-specific metabolic therapies.

(3) Expanding the organelle crosstalk network: cristae do not function in isolation. A critical emerging area is the communication between cristae junctions and other organelles, particularly the endoplasmic reticulum at mitochondria-associated membranes. Investigating how stress signals from the endoplasmic reticulum are transmitted across the outer membrane to directly influence MICOS stability and cristae curvature will shed light on integrated cellular stress responses.

(4) Targeting cristae for precision medicine: finally, insights into cristae mechanisms must guide the development of new therapies. Moving beyond general antioxidants, the field should focus on structure-based drug design targeting specific cristae components. Developing molecules that allosterically stabilize the OPA1-cardiolipin interaction or mimic the membrane-shaping properties of MICOS offers a promising strategy to reverse mitochondrial dysfunction in neurodegenerative and metabolic diseases.

Together, these advances highlight the deep evolutionary link between prokaryotic systems and contemporary energy demands, promising a new era where cristae biology drives innovations in cellular bioengineering and precision medicine.